- Home
- PRME vs TROX Comparison
PRME vs TROX Comparison
Compare PRME & TROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | TROX |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 680.2M |
| IPO Year | 2022 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PRME | TROX |
|---|---|---|
| Price | $3.48 | $4.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | ★ $6.42 | $4.69 |
| AVG Volume (30 Days) | 3.8M | ★ 4.8M |
| Earning Date | 11-07-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 4.80% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,977,000.00 | ★ $2,844,000,000.00 |
| Revenue This Year | $111.80 | N/A |
| Revenue Next Year | N/A | $3.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 647.13 | N/A |
| 52 Week Low | $1.11 | $2.86 |
| 52 Week High | $6.94 | $10.60 |
Technical Indicators
Market Signals| Indicator | PRME | TROX |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 55.59 |
| Support Level | $3.29 | $4.08 |
| Resistance Level | $4.12 | $4.30 |
| Average True Range (ATR) | 0.24 | 0.19 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 18.47 | 28.64 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About TROX Tronox Holdings plc (UK)
Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.